Bovine Mastitis Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Bovine mastitis represents one of the most financially burdensome diseases in commercial dairy farming, with treatment and prevention products forming a specialized segment of the broader veterinary pharmaceuticals market. The market encompasses antibiotics, intramammary infusions, vaccines, rapid diagnostic tests, and complementary management solutions. Official figures place the market at $2.046 billion in 2025, with projections to reach approximately $2.7 billion by 2030 as dairy operations increasingly prioritize herd health and milk quality standards.

• •Market valued at $2.046 billion in 2025, projected to reach $2.705 billion by 2030
• •Mastitis accounts for 32.2% of total veterinary drug spending in cattle herds
• •Includes drugs, diagnostics, and management solutions across the dairy supply chain

Rising global population and increasing demand for dairy products are fundamental catalysts, as intensified production systems face higher disease transmission risks and stricter milk quality regulations. The enormous economic toll of mastitis, with industry losses ranging from $19.7 billion to $35 billion annually, creates strong financial incentive for dairy producers to invest in prevention and treatment. Growing awareness of antibiotic resistance concerns is also reshaping purchasing behavior toward vaccines, diagnostics, and alternative therapies.

• •Global dairy intensification driven by rising population and milk demand
• •Industry-wide economic losses from mastitis estimated at $19.7-35 billion per year
• •Antimicrobial resistance concerns accelerating shift toward vaccines and diagnostics

The market is broadly segmented into therapeutics, primarily antibiotics and anti-inflammatories, and diagnostics, including rapid test kits and laboratory services. Geographically, North America and Europe currently dominate market share due to large-scale dairy operations, advanced veterinary infrastructure, and stringent regulatory frameworks. Asia-Pacific is emerging as the fastest-growing region, fueled by expanding dairy sectors in countries such as China and India, while Latin America also presents significant expansion opportunities.

• •Primary segments: drugs (antibiotics, intramammary treatments) and diagnostics
• •North America and Europe lead in market share; Asia-Pacific is the fastest-growing region
• •Dairy sector expansion in emerging economies driving regional demand growth

What are the recent trends and outlook?

Research and development is increasingly focused on alternatives to conventional antibiotics, including plant-derived compounds, nanoparticles, and immunomodulatory therapies, reflecting both regulatory pressure and consumer demand for residue-free milk. Precision dairy farming technologies, such as automated mastitis detection systems and data-driven herd management platforms, are gaining traction in developed markets. The market is expected to maintain steady growth through 2030, supported by ongoing dairy intensification, global milk production expansion, and heightened biosecurity standards.

• •Growing investment in antibiotic alternatives: botanical extracts, nanoparticles, and immunotherapies
• •Adoption of automated monitoring and precision farming technologies for early detection
• •Projected continuation of 5.74% annual growth through 2030 amid global dairy expansion